Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment.
Title | Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment. |
Publication Type | Journal Article |
Year of Publication | 2015 |
Authors | Anastasilakis, A. D., Polyzos S. A., Makras P., Gkiomisi A., Sakellariou G., Savvidis M., Papatheodorou A., Kokkoris P., & Terpos E. |
Journal | Expert Opin Ther Targets |
Volume | 19 |
Issue | 3 |
Pagination | 299-306 |
Date Published | 2015 Mar |
ISSN | 1744-7631 |
Keywords | Aged, Antibodies, Monoclonal, Humanized, Antigens, CD, Bone Density, Bone Density Conservation Agents, Case-Control Studies, Denosumab, Diphosphonates, Female, Humans, Imidazoles, Lumbar Vertebrae, Middle Aged, Nerve Tissue Proteins, Osteoporosis, Postmenopausal, Parathyroid Hormone, Receptors, Cell Surface, Semaphorins, Teriparatide, Vitamin D, Zoledronic Acid |
Abstract | OBJECTIVE: The evaluation of circulating semaphorin-4D (sema4D) and plexin-B1 in postmenopausal women with low bone mass and the effect of antiresorptive or osteoanabolic treatment. |
DOI | 10.1517/14728222.2014.983078 |
Alternate Journal | Expert Opin. Ther. Targets |
PubMed ID | 25395071 |